CHRIS BISHOP (National): Turning away from the border for a little bit: a couple of questions in relation to the actual health response. The first is: does he have any more advice on when Paxlovid or molnupiravir—but particularly Paxlovid, because that seems to be the more effective of the two—will become available for use in New Zealand? 